The study found that semaglutide users who took the drug for at least a year had a stunning 48 percent lower dementia risk than patients that took sitagliptin, an older diabetes drug.
Semaglutide users were also found to have a 28 percent lower chance of smoking than those who took glipizide, indicating potential benefits in combating substance misuse.
Collection
[
|
...
]